Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBeTA: IVB or IVTA with Laser for DME
NCT02310295Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2009
- Primary completion
- Dec 2011
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
01
Overview
Randomised trial of bevacizumab and triamcinolone in diabetic macular edema (DME) (3 arms), sponsored by Universidade de São Paulo. Primary endpoints: Central subfield macular thickness at 12 months and Visual acuity at 12 months. Started Jan 2009; status: completed.
02
Drugs
bevacizumabtriamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02310295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02310295.